Categories AlphaGraphs, Consumer, Earnings
JNJ Earnings: Johnson & Johnson reports higher sales and adj. profit for Q2
Johnson & Johnson (NYSE: JNJ) reported an increase in sales and adjusted profit for the second quarter of 2022 when strong performance by the core pharmaceuticals segment more than offset lower sales in the other operating divisions. The pharma giant’s shares made modest gains early Tuesday following the announcement.
Net sales increased 3% year-over-year to $24.0 billion during the second quarter, reflecting the strength and resilience of the company’s market leadership in the midst of macroeconomic challenges.
Second-quarter adjusted earnings moved up to $2.59 per share from $2.48 per share in the prior-year period. Unadjusted profit was $4.81 billion or $1.80 per share, compared to $6.28 billion or $2.35 per share a year earlier.
Check this space to read management/analysts’ comments on Johnson & Johnson’s Q2 2022 earnings
“Our solid second quarter results across Johnson & Johnson reflect the strength and resilience of our Company’s market leadership in the midst of macroeconomic challenges,” said Joaquin Duato, chief executive officer of Johnson & Johnson.
Prior Performance
Most Popular
What to look for when Hormel Foods (HRL) reports Q4 2023 earnings
Shares of Hormel Foods Corporation (NYSE: HRL) were down over 1% on Monday. The stock has dropped 29% year-to-date. The food company is set to report its fourth quarter 2023 earnings
Kroger set to report Q3 results. Here’s everything you need to know
The Kroger Co. (NYSE: KR), a leading grocery retailer that operates both in-store and online, will be reporting earnings this week. The company, which is preparing to acquire rival retailer
Earnings Preview: Salesforce will likely deliver another strong quarter
Salesforce, Inc. (NYSE: CRM) achieved accelerated sales growth and profitability in recent quarters, in line with its transformation goal. The customer relationship management platform bets on new opportunities in generative
